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Purpose: To report a case of Granulomatosis with Polyangiitis presenting with rare ﬁndings of cicatricial
entropion progressing to signiﬁcant symblepharon and fornix obliteration.
Observations: An otherwise healthy patient with initial presentation ﬁndings of lower lid entropion with
minimal cicatricial changes and a corneal ulcer. Management with an entropion Jones procedure repair
produced good early postoperative results. 2 months post entropion repair, this patient represented with
rapid progression to severe corneal ulceration, symblepharon formation and total obliteration of lower
fornix and near complete obliteration of upper fornix of the left eye with concurrent acute kidney injury.
He fulﬁlled diagnostic criteria for Granulomatosis with Polyangiitis (GPA). Systemic immunosuppressive
treatment with prednisone and cyclophosphamide allowed acute kidney injury to recover however
progressive cicatricial scarring ensued.
Conclusions and importance: Cicatricial entropion is a very rare presentation of GPA which can take years
to progress however with surgical intervention, rapid recurrence and severe tarsal-conjunctival disease
progression can ensue despite systemic immunosuppressive therapy. To prevent such unexpected sur-
gical complication, we recommend a thorough systemic evaluation prior to consideration of lid surgery
in any cases of cicatrising conjunctivitis presentation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Granulomatosis with polyangiitis (GPA), formerly known as
Wegner’s granulomatosis, is a rare systemic inﬂammatory disease
affecting small to medium size blood vessels, with an estimated
annual incidence of 5e10 cases per million people.1 Historically a
fatal disease if untreated, recognition of disease activity is critical
for treatment initiation, as early organ damage is a predictor of poor
outcome.2,3 GPA belongs to the group of antineutrophil cytoplasmic
antibody (ANCA)-associated vasculitides, of which microscopic
polyangiitis (MPA) and Churg-Strauss syndrome (CSS) also belong.
Several diagnostic criteria exist (American college of Rheuma-
tology, Chapel Hill Consensus Conference, European Medicines
Agency) 4e6 for classiﬁcation of these similar groups of diseases.
Ophthalmologic manifestations have been reported across all the
ANCA associated vasculitides however, thesemost commonly occur
in GPA patients, where up to half of the cases may develop eyegton Eye clinic, Wellington
w Zealand.
nne).
Inc. This is an open access article uinvolvement.7,8 Such ocular presentations are diverse, ranging from
more common orbital disease, conjunctivitis, scleral/episcleral
disease, to corneal ulceration, uveitis, retinal vasculitis, optic neu-
ropathy, orbital masses and nasolacrimal duct involvement 7,9. Of
the rarer presentations reported in the literature, GPA causing
cicatricial scarring has been reported in only a handful of cases.10e12
Here we report a case of GPA presenting with cicatrising disease
causing entropion and signiﬁcant symblepharon formation.2. Case report
An 84 year old male presented with a 2 month history of left eye
irritation and decreased visual acuity. His past ocular history
included a left cataract extraction 3 years previously, further
complicated by a dislocation of IOL requiring a vitrectomy and IOL
exchange. On the right side he has had a previous penetrating eye
injury, with resulting aphakia after repair. Right corrected visual
acuity was 6/18 however, our patient was not using corrective
lenses for this eye.
On presentation to our clinic, ﬁndings included a mildly
inﬂamed a left eye with visual acuity reduced from 6/9 to 6/36.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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scarring. Associated with these changes was an inferior corneal
ulcer with a few anterior chamber cells. Fundal examination was
not possible. There were no complaints or acute ﬁndings with his
right eye and he otherwise denied being generally unwell at the
time.
Initial management involved topical chloramphenicol ointment
and entropion temporised with tape. He subsequently underwent a
left lower lid entropion repair (Jones Procedure) 5 days later.
Topical antibiotics and lubrication were continued postoperatively.
Post-operative reviews were conducted weekly for the ﬁrst month,
with the 4th week follow-up showing good left lower lid position
with a reasonable fornix and complete healing of the corneal ulcer.
Mild left upper lid swelling was noted then, with suspicious
trichiatic eyelashes epilated. Further review at 10 weeks post-op
was planned to assess the recovery.
Within the same week of the planned 10 week review, we
received a referral from our patient’s family doctor requesting an
urgent Ophthalmology review as now there was a new history of
left eye pain, further decreased visual acuity and a recent 8 day
hospital admission to another regional hospital where he was
treated for acute kidney injury thought secondary to hypovolaemia.
Prompt review of our patient now showed signiﬁcant new ul-
ceration of the left lower lid margin with total obliteration of the
lower fornix and symblepharon formation (Fig. 1). There was also a
new corneal ulcer with inferior corneal melt. An initial diagnosis of
an inﬂammatory process was made and topical antibiotics and
topical prednisolone were commenced. He was admitted for
further investigation as the suspicion was an underlying systemic
vasculitic cause.
Detailed medical workup for admission revealed a history of
chronic sinusitis pre dating surgery however from about 2 weeks
post-surgery, progressive post nasal drip and blood stained mucus,
together with lethargy and a 15 kg weight loss was recalled by the
patient. Examination also showed right nostril scarring and clots.
Investigations included blood results of white blood cells
9.5  10(9)/L (WBC), normal eosinophils, CRP 89 mg/L, creatinine
165 mmol/L, ANCA positive, antinuclear antibody (ANA) negative,
anti-proteinase 3 antibody (PR3) of 507 units/ml, anti-
myeloperoxidase antibody (MPO) of 6 units/ml, red blood cells
(RBC) and albumin in urine and an unremarkable chest X-ray. Renal
biopsy showed pauci-immune crescentic glomerulonephritis. MRI
orbits showed a slightly asymmetrical enlarged left lacrimal gland,
asymmetric increased T2 signal and contrast enhancement leftFig. 1. Left lower lid margin ulceration with symblepharon formation and inferior
corneal melt 2 months after entropion repair.eyelid as well as above left globe extending medially and mucosal
thickening of the right maxillary sinus (Fig. 2).
The clinical presentation and results suggested the underlying
cause was GPA with renal, upper respiratory and ocular involve-
ment and as such, systemic prednisone, cyclophosphamide and
prophylactic cotrimoxazole were subsequently commenced under
multidisciplinary care. Over the following 3 months on systemic
therapy, renal function normalised, inﬂammatory markers and PR3
antibodies decreased and topical steroids were subsequently
stopped after the initial 2 weeks. Some initial ocular improvement
was noted, with reduction in amount of adhesions, healing of the
corneal ulcer and ulcerated lid margins however at the most recent
review some 4 months after initiation of systemic therapy, the left
lower lid symblepharon remains with complete obliteration of the
fornix and extensive corneal scarring resulting in hand motions
only vision in the left eye (Fig. 3).
Both verbal and written informed consent was given from the
patient for use of case medical photography for publication
purposes.3. Discussion
Under the 1990 American College of Rheumatology criteria for
classiﬁcation for GPA, our patient fulﬁls two positive criteria of
nasal inﬂammation and kidneymicrohaematuria.4 Such respiratory
and biopsy conﬁrmed kidney involvement, combined with positive
ANCA, PR3 and negativeMPO, certainly makes a diagnosis of GPA in
our patient.13 Conjunctival biopsy was not performed in this case as
consideration of the risk of inducing further trauma and inﬂam-
mationwas deemed rather high compared to any further beneﬁts a
tissue diagnosis might have added at the time.
Literature review of ocular manifestations of GPA typically
report non-speciﬁc conjunctivitis affecting 16e18% of GPA pa-
tients.7,8,10 Robinson et al. has further in detail described tarsal-
conjunctival disease to include conjunctival hyperaemia, granulo-
matous lesions, necrosis, ﬁbrovascular proliferation, ﬁbrous scar,
corneal involvement and trichiasis/entropion.10
To date, only 6 cases of GPA causing cicatricial entropion have
been reported and of these, one patient developed symblepharon
formation, another with ﬁbrovascular proliferation extending over
the pupillary axis and a third patient with both of the aforemen-
tioned features.10,14 Our case demonstrates a severe presentation of
these rare GPA ﬁndings, with early cicatricial entropion developingFig. 2. T2 weight magnetic resonance imaging of the orbits showed asymmetric
increased signal and contrast enhancement left eyelid as well as above left globe
extending medially and mucosal thickening of the right maxillary sinus.
Fig. 3. Progressive left eye conjunctival and corneal scarring with lower fornix oblit-
eration 4 months after systemic immunosuppressant therapy.
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tion. Of note, our patient did undergo an entropion repair
approximately 10 weeks prior to representation and establishment
of GPA diagnosis. With very few cases, limited conclusions can be
made regarding the role of medical and surgical intervention in
such cases. Robinson et al. does report one patient who underwent
excision of ﬁbrovascular tissue over the cornea which had been
slowly progressive over 20 months. Despite systemic prednisone
over the perioperative period, this patient developed rapid disease
recurrence with the ﬁbrovascularisation process entering the pu-
pillary axis within 3 months. Described also within this study was a
second patient where systemic prednisone and methotrexate did
not alter the progressive ﬁbrovascular tissue growth and entropion
formation over a course of 3 years.10 Meier et al. reports a case of
cicatrising conjunctivitis where no systemic therapy was initiated
but treatment consisted of blepharitis regime (including topical
steroids). This patient also had progressive tarsal scarring and cic-
atrising entropion over the following 2 years.11
Despite our patient being initiated on systemic immunosup-
pressant therapy when GPA diagnosis was conﬁrmed, review 4
months later continued to show extensive corneal and conjunctival
scarring with symblepharon and fornix obliteration. Our case
shows similarity to the ﬁndings of Robinson et al., whom noted that
in their small number of cases, tarsal-conjunctival disease activity
was largely unaffected by systemic immunosuppressive therapy.10
With or without systemic therapy, cicatricial entropion and ﬁbro-
vascular changes tended to progress over years 10,11 however rapid
recurrence occurred within the one previously reported patient
with surgical excision and certainly in our own case, ocular disease
progression was rapid with severe fornix scarring and corneal ul-
ceration. The extent and rapidity of disease activity in our patient
does pose further questions regarding potential predictors of visual
outcome. Our patient represented during an acute episode of sys-
temic inﬂammation and had not previously been initiated on sys-
temic treatment, as well as recent surgical intervention for
entropion. With comparison to the patient receiving surgical
intervention in Robinson et al., it is plausible that further traumatic
insult resulting in increased site inﬂammation could have a role in
rapidity of disease recurrence and progression. Such is an obser-
vation made in this inﬂammatory disease where the underlying
pathophysiology is still not fully understood. Similarly in othercases of progressive cicatrizing conjunctivitis such as ocular mu-
cous membrane pemphigoid, lid surgery is known to exacerbate
local inﬂammation and candidates often undergo a period of
perioperative immunosuppression in hopes to control
inﬂammation.15
Whilst cicatricial scarring resulted in poor visual outcome for
our patient, fortunately with systemic immunosuppressive therapy
our patient has achieved systemic disease remission with normal-
ised kidney function. Further close monitoring and maintenance
treatment will likely be required given the high likelihood of sys-
temic disease relapse in ANCA associated vasculitis patients.16
Given the previously reported association between tarsal-
conjunctival disease and subglottic stenosis.10, our patient has
also been referred to otorhinolaryngology for further assessment.4. Conclusion
Cicatricial entropion is a rare disease manifestation of GPA
which typically follows a slow course of progressive scarring un-
affected by systemic immunosuppressant therapy. Whilst the un-
derlying pathophysiology of GPA is still unclear, we believe that
surgical intervention may potentially induce rapid cicatricial dis-
ease progression with resultant signiﬁcant poor outcomes. As a
result, we would advised that any cases of cicatrising conjunctivitis
under consideration for lid surgery be met with a thorough sys-
temic evaluation with the hopes of preventing late diagnosis of an
underlying systemic inﬂammatory disease process.References
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